Biologics

Biologics is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Biologics, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Why watch Biologics

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Biologics news

The latest feed items from companies currently grouped under Biologics.

1. 01
   2026-09-02 20:05 EST

   STTKShattuck Labs Announces Participation in Upcoming September Investor Conferences

   Source: Shattuck Labs

2. 02
   2026-09-01 20:30 EST

   IBIOiBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

   Source: Ibio Inc

3. 03
   2026-08-31 13:30 EST

   CHRSCoherus to Participate in Upcoming Investor Conferences

   Source: Coherus BioSciences, Inc.

4. 04
   2026-08-31 08:30 EST

   ALVOMatvæla- og lyfjastofnun Bandaríkjanna (FDA) tekur til afgreiðslu umsókn Alvotech um markaðsleyfi fyrir fyrirhugaða hliðstæðu við Entyvio í sprautu eða lyfjapenna

   Source: Alvotech

5. 05
   2026-08-31 08:30 EST

   ALVOAlvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations

   Source: Alvotech

6. 06
   2026-08-28 11:00 EST

   IBIOiBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

   Source: Ibio Inc

7. 07
   2026-08-27 13:44 EST

   ENTXCorrection: Entera to Participate in Upcoming Fall Investor Conferences

   Source: Entera Bio

8. 08
   2026-08-27 12:00 EST

   ALVOAlvotech tekur þátt í ráðstefnum fyrir fjárfesta í september

   Source: Alvotech

9. 09
   2026-08-27 12:00 EST

   ALVOAlvotech to present at upcoming investor conferences in September

   Source: Alvotech

10. 10
    2026-08-27 12:00 EST

    ENTXEntera to Participate in Upcoming Fall Investor Conferences

    Source: Entera Bio

11. 11
    2026-08-21 13:00 EST

    ALVOAlvotech kynnir samning við Lotus Pharmaceutical um markaðssetningu á fyrirhuguðum hliðstæðum við durvalumab og emicizumab í Bandaríkjunum og á völdum mörkuðum í Asíu

    Source: Alvotech

12. 12
    2026-08-21 13:00 EST

    ALVOAlvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

    Source: Alvotech

13. 13
    2026-08-19 20:30 EST

    ALVOAlvotech birtir árshlutauppgjör fyrir fyrstu sex mánuði ársins 2026

    Source: Alvotech

14. 14
    2026-08-19 20:30 EST

    ALVOAlvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

    Source: Alvotech

15. 15
    2026-08-18 12:00 EST

    ENTXEntera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation

    Source: Entera Bio

16. 16
    2026-08-17 21:33 EST

    CHRSCoherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights

    Source: Coherus BioSciences, Inc.

17. 17
    2026-08-13 05:00 EST

    PHARPharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older

    Source: Pharming Group

18. 18
    2026-08-11 10:15 EST

    STTKShattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights

    Source: Shattuck Labs

19. 19
    2026-08-10 12:00 EST

    ALVOAlvotech birtir uppgjör fyrri árshelmings 2026 þann 19. ágúst nk.

    Source: Alvotech

20. 20
    2026-08-10 12:00 EST

    ALVOAlvotech to Report Financial Results for H1 2026

    Source: Alvotech

Companies in Biologics

16 companies tagged with Biologics.

Frequently Asked Questions